About POC HIV Testing
POC HIV testing is used to screen HIV antibodies. They can be performed in hospitals, clinics, and home care settings, and the results of these tests are available within a few minutes.
Technavio’s analysts forecast the Global POC HIV Testing Market to grow at a CAGR of 7.03% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the POC HIV testing market. To calculate the market size, the report considers the revenue generated by sales of POC HIV testing equipment and consumables across the globe.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, POC HIV testing market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• BD
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
Market driver
• Increase in HIV affected population worldwide
• For a full, detailed list, view our report
Market challenge
• Product recalls
• For a full, detailed list, view our report
Market trend
• Technological advances
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• POC HIV testing consumables – Market size and forecast 2017-2022
• POC HIV testing systems – Market size and forecast 2017-2022
• Market opportunity by product
PART 08: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances
• Growing collaborations and partnerships
• Presence of government funding
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
PART 14: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global POC infectious disease testing market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global POC HIV testing market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global POC HIV testing market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global POC HIV testing market by product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global POC HIV testing consumables market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global POC HIV testing consumables market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global POC HIV testing systems market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global POC HIV testing systems market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global POC HIV testing market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: POC HIV testing market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: POC HIV testing market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: POC HIV testing market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: POC HIV testing market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: POC HIV testing market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: POC HIV testing market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Number of children living with HIV in various countries 2016
Exhibit 39: Product recalls of HIV tests
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott – Overview
Exhibit 46: Abbott – Business segments
Exhibit 47: Abbott – Organizational developments
Exhibit 48: Abbott – Geographic focus
Exhibit 49: Abbott – Segment focus
Exhibit 50: Abbott – Key offerings
Exhibit 51: Abbott – Key customers
Exhibit 52: BD – Overview
Exhibit 53: BD – Business segments
Exhibit 54: BD – Organizational developments
Exhibit 55: BD – Geographic focus
Exhibit 56: BD – Segment focus
Exhibit 57: BD – Key offerings
Exhibit 58: BD – Key customers
Exhibit 59: bioMérieux – Overview
Exhibit 60: bioMérieux – Business segments
Exhibit 61: bioMérieux – Organizational developments
Exhibit 62: bioMérieux – Geographic focus
Exhibit 63: bioMérieux – Segment focus
Exhibit 64: bioMérieux – Key offerings
Exhibit 65: bioMérieux – Key customers
Exhibit 66: Danaher – Overview
Exhibit 67: Danaher – Business segments
Exhibit 68: Danaher – Organizational developments
Exhibit 69: Danaher – Geographic focus
Exhibit 70: Danaher – Segment focus
Exhibit 71: Danaher – Key offerings
Exhibit 72: Danaher – Key customers
Exhibit 73: F. Hoffmann-La Roche – Overview
Exhibit 74: F. Hoffmann-La Roche – Business segments
Exhibit 75: F. Hoffmann-La Roche – Organizational developments
Exhibit 76: F. Hoffmann-La Roche – Geographic focus
Exhibit 77: F. Hoffmann-La Roche – Segment focus
Exhibit 78: F. Hoffmann-La Roche – Key offerings
Exhibit 79: F. Hoffmann-La Roche – Key customers
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• POC HIV testing consumables – Market size and forecast 2017-2022
• POC HIV testing systems – Market size and forecast 2017-2022
• Market opportunity by product
PART 08: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances
• Growing collaborations and partnerships
• Presence of government funding
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
PART 14: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global POC infectious disease testing market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global POC HIV testing market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global POC HIV testing market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global POC HIV testing market by product – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global POC HIV testing consumables market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global POC HIV testing consumables market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global POC HIV testing systems market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global POC HIV testing systems market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global POC HIV testing market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: POC HIV testing market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: POC HIV testing market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: POC HIV testing market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: POC HIV testing market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: POC HIV testing market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: POC HIV testing market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Number of children living with HIV in various countries 2016
Exhibit 39: Product recalls of HIV tests
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott – Overview
Exhibit 46: Abbott – Business segments
Exhibit 47: Abbott – Organizational developments
Exhibit 48: Abbott – Geographic focus
Exhibit 49: Abbott – Segment focus
Exhibit 50: Abbott – Key offerings
Exhibit 51: Abbott – Key customers
Exhibit 52: BD – Overview
Exhibit 53: BD – Business segments
Exhibit 54: BD – Organizational developments
Exhibit 55: BD – Geographic focus
Exhibit 56: BD – Segment focus
Exhibit 57: BD – Key offerings
Exhibit 58: BD – Key customers
Exhibit 59: bioMérieux – Overview
Exhibit 60: bioMérieux – Business segments
Exhibit 61: bioMérieux – Organizational developments
Exhibit 62: bioMérieux – Geographic focus
Exhibit 63: bioMérieux – Segment focus
Exhibit 64: bioMérieux – Key offerings
Exhibit 65: bioMérieux – Key customers
Exhibit 66: Danaher – Overview
Exhibit 67: Danaher – Business segments
Exhibit 68: Danaher – Organizational developments
Exhibit 69: Danaher – Geographic focus
Exhibit 70: Danaher – Segment focus
Exhibit 71: Danaher – Key offerings
Exhibit 72: Danaher – Key customers
Exhibit 73: F. Hoffmann-La Roche – Overview
Exhibit 74: F. Hoffmann-La Roche – Business segments
Exhibit 75: F. Hoffmann-La Roche – Organizational developments
Exhibit 76: F. Hoffmann-La Roche – Geographic focus
Exhibit 77: F. Hoffmann-La Roche – Segment focus
Exhibit 78: F. Hoffmann-La Roche – Key offerings
Exhibit 79: F. Hoffmann-La Roche – Key customers
